Sandoz Strikes Shionogi Partnership as Part of Pain Play

 
• By Aidan Fry
  
Toilet
By licensing European rights to Shionogi's Rizmoic opioid-induced constipation treatment, Sandoz is seeking to strengthen its pain portfolio • Source: Shutterstock

More from Deals

More from Business